课题基金 / 基金详情

Tuberculosis elimination in Australia through targeting latent infection

Tuberculosis elimination in Australia through targeting latent infection
澳大利亚通过针对潜伏感染消除结核病
批准号:
nhmrc : 1193750
负责人:
金额:
$95.0万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Investigator Grants
财政年份:
2021
资助国家:
澳大利亚
项目状态:
未结题
起止时间:
2021-01-01 至 2025-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
澳大利亚已承诺减少患结核病的人数,最终消灭结核病。需要确定高危人群,这意味着大幅扩大对潜伏性结核病的发现和治疗。这项研究将评估消除结核病的影响、成本效益和社区优先事项,并引入以全科医生为基础的治疗服务,以提供安全和可获得的护理。它将为大规模消除结核病的计划提供基础。
英文摘要
Australia has committed to reducing the number of people who become sick with tuberculosis (TB), towards eventual elimination. Identification of those at risk is needed, which means significant expansion of detection and treatment of latent TB. This research will evaluate impact, cost-effectiveness and community priorities around TB elimination, and introduce a GP-based treatment service for safe and accessible care. It will provide a basis for large-scale programs towards TB elimination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金